Rader reasoned that the expedited generic drug approval process created by the Act required drug testing by the generic manufacturer prior to patent expiration and that § 271 (e) (1) thus covers only ...

Can you please introduce yourself and tell us about your background in process safety testing? My name is John Weaver. I earned a bachelor's degree in chemistry from Penn State University many years ...